Double-blind controlled investigation of bilateral prefrontal transcranial magnetic stimulation for the treatment of resistant major depression

Colleen K. Loo*, P. B. Mitchell, V. M. Croker, G. S. Malhi, W. Wen, S. C. Gandevia, P. S. Sachdev

*Corresponding author for this work

    Research output: Contribution to journalArticlepeer-review

    111 Citations (Scopus)

    Abstract

    Background. The efficacy and safety of bilateral prefrontal repetitive transcranial magnetic stimulation (rTMS) for treating resistant major depression were examined in a double-blind, placebo-controlled study. Method. Nineteen medication-resistant depressed subjects were randomly assigned to 3 weeks of active or sham rTMS. Effects on mood and neuropsychological function were assessed. Results. Both groups improved significantly in mood over the 3 weeks, but there was no significant difference between active and sham treatments. There were no significant neuropsychological effects. Conclusions. Bilateral rTMS was not superior to sham in treating resistant depression in this pilot study, but caused no neuropsychological impairment.

    Original languageEnglish
    Pages (from-to)33-40
    Number of pages8
    JournalPsychological Medicine
    Volume33
    Issue number1
    DOIs
    Publication statusPublished - Jan 2003

    Keywords

    • ELECTROCONVULSIVE-THERAPY
    • MOTOR CORTEX
    • MENTAL STATE
    • MOOD
    • TRIAL
    • RTMS
    • SLOW
    • EXCITABILITY
    • MANIA
    • ECT

    Fingerprint Dive into the research topics of 'Double-blind controlled investigation of bilateral prefrontal transcranial magnetic stimulation for the treatment of resistant major depression'. Together they form a unique fingerprint.

    Cite this